Tamara Vasiljevik

Title: Tamara Vasiljevik: Innovator in Cannabinoid Research

Introduction

Tamara Vasiljevik is a notable inventor based in Lawrence, Kansas. She has made significant contributions to the field of cannabinoid research, particularly in the development of compounds that target cannabinoid receptors. Her work focuses on addressing critical health issues such as alcoholism, drug abuse, and obesity.

Latest Patents

Tamara Vasiljevik holds a patent for the "Use of the aminoalkylindole JWH-073-M4 and related compounds as neutral CB1 receptor antagonists for the treatment of alcoholism, drug abuse, obesity, and obesity-related diseases." This patent describes novel alkylindoles that bind tightly to cannabinoid receptors, acting as neutral antagonists for the cannabinoid 1 receptor and agonists for the cannabinoid 2 receptor. These compounds are particularly useful in treating alcoholism, drug abuse, and obesity-related conditions.

Career Highlights

Throughout her career, Tamara has worked with prestigious institutions such as the University of Arkansas and the University of Kansas. Her research has garnered attention for its potential applications in therapeutic settings, particularly in combating addiction and obesity.

Collaborations

Tamara has collaborated with esteemed colleagues, including Paul L. Prather and Thomas Edward Prisinzano. These partnerships have contributed to the advancement of her research and the development of innovative solutions in cannabinoid therapy.

Conclusion

Tamara Vasiljevik's work exemplifies the intersection of innovation and health science. Her contributions to cannabinoid research hold promise for addressing significant public health challenges.